4 結果
FIELD OF THE INVENTION
This invention relates to dietary supplement compositions and methods of administering such compositions to treat obesity. More particularly the invention relates to compositions and methods useful for reducing the rate of weight gain in an overweight and/or obese person, to
FIELD OF THE INVENTION
The invention is related generally to neuromodulation, in particular to stimulating the sympathetic nervous system to treat obesity.
BACKGROUND
Obesity results from an imbalance between food intake and energy expenditure, such that there is a net increase in fat reserves.
FIELD OF THE INVENTION
The present invention relates to compounds which are inhibitors of sodium dependent glucose co-transporter-2 (SGLT-2), methods of making them, and uses thereof.
BACKGROUND OF THE INVENTION
According to the World Health Organization (WHO), in 2009, more than 220 million people
FIELD OF THE INVENTION
The present invention relates to novel substituted heterocyclic derivatives which modulate blood glucose levels, triglyceride levels, insulin levels and non-esterified fatty acid (NEFA) levels, and thus are particularly useful in the treatment of diabetes and obesity, and to a